Attached files

file filename
8-K - 8-K - BODY CENTRAL CORPa13-13874_38k.htm

Exhibit 99.1

 

GRAPHIC

 

Body Central Corp. Announces Second Quarter 2013 Financial Results

 

Jacksonville, FL — August 1, 2013 — Body Central Corp. (Nasdaq: BODY) today announced financial results for the second quarter of 2013.

 

Highlights for the thirteen weeks ended June 29, 2013:

 

·                  Net revenues for the quarter decreased 5.3% to $75.1 million, compared to $79.4 million for the second quarter of 2012.

·                  Store sales decreased 2.1% to $66.9 million due to a comparable-store sales decrease of 13.2%, partially offset by a net increase of 29 stores over the same quarter last year.

·                  Direct sales decreased by 25.0% to $8.3 million from $11.0 million over the same quarter last year.

·                  The loss from operations includes a $10.4 million asset impairment charge related to the direct business.  The loss from operations including this impairment was $15.2 million, as compared to income from operations of $5.5 million for the second quarter in 2012.  Excluding the $10.4 million impairment charge, the loss from operations would have been $4.8 million.

·                  The net loss was $12.8 million, or ($0.78) per diluted share based on 16.3 million weighted average shares outstanding. This includes $10.4 million, or ($0.63) per diluted share in an asset impairment charge related to the direct business.  Excluding the $10.4 million impairment charge, the net loss would have been $2.4 million, or ($0.15) per diluted share.  Net income for the second quarter of 2012 was $3.4 million, or $0.21 per diluted share based on 16.4 million weighted average shares outstanding.

·                  The Company opened 9 new stores and closed 2 stores during the second quarter and operated 286 stores as of June 29, 2013.

 

Brian Woolf, Body Central’s CEO, stated: “While we did not anticipate improvement in our results until the second half, our second quarter performance was more challenging than we expected.  During the quarter we took aggressive steps to clear inventory to make room for the new product assortment that we believe better reflects the tastes of our customer.  We also brought product in earlier than last year in order to set the floors for the Back-to-School season, which contributed to higher inventory levels at the end of the quarter.  Our comparable sales decrease and merchandise margin pressure was the result of a decline in store traffic combined with deep markdowns.  In the direct business, we saw a significant decline in sales and margin as the result of our strategic decision to more closely align our catalog and website with the offering in our retail stores.”

 

Mr. Woolf added: “Our objective going forward is that our merchandise assortment will be fresh, stylish and trend driven.  To this end, we continue to enhance our planning tools, vendor resources, market intelligence and consumer understanding.  We are confident in our strategic direction that sets a foundation to rejuvenate the Body Central brand and drive improved performance across our channels.  While we fully expect our initiatives to take hold, near-term business will likely remain challenging and require a more promotional environment in our stores.”

 

Mr. Woolf concluded: “We believe that by creating a consistent brand message and product offering across all channels, and developing a targeted, compelling marketing program, we will be able to reengage our customer and drive long-term sales growth and profitability.”

 

Balance Sheet highlights as of June 29, 2013:

 

Cash, cash equivalents and short-term investments were $38.8 million at the end of the second quarter of 2013 compared to $42.0 million at the end of the second quarter in the prior year.

 



 

Average store inventories increased 8.6% and 7.3%, respectively, at cost and in units from one year ago, partially attributed to the earlier flow of fall goods into our stores.

 

The Company had no long-term debt as of the end of the second quarter 2013 and 2012.

 

Reported results are preliminary and remain subject to adjustment until the filing of our Form 10-Q with the SEC.

 

Conference Call Information

 

A conference call to discuss second quarter financial results is scheduled for today August 1, 2013, at 4:30 PM Eastern Time. The conference call will also be webcast live at www.bodycentral.com. To access the replay of this call, please dial (877) 870-5176 and enter pin number 7837235. The replay is available until August 15, 2013. A replay of this web cast will also be available on the Investor Relations section of the Company’s website, www.bodycentral.com, within two hours of the conclusion of the call and will remain on the website for ninety days.

 

About Body Central

 

Founded in 1972, Body Central Corp. is a growing, multi-channel, specialty retailer offering on trend, quality apparel and accessories at value prices. As of July 31, 2013 the Company operated 289 specialty apparel stores in 28 states under the Body Central and Body Shop banners, as well as a direct business comprised of a Body Central catalog and an e-commerce website at www.bodycentral.com. The Company targets women in their late teens and twenties from diverse cultural backgrounds who seek the latest fashions and a flattering fit. The Company’s stores feature an assortment of tops, dresses, bottoms, jewelry, accessories and shoes sold primarily under the Company’s exclusive Body Central® and Lipstick® labels.

 

CONTACT:

 

Tom Stoltz

Chief Operating Officer and Chief Financial Officer

904-207-6720

tstoltz@bodyc.com

 

Safe Harbor Language

 

Certain statements in this release are “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “guidance,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “anticipates,” and similar expressions are used to identify these forward-looking statements. Forward-looking statements are based on our current expectations and assumptions, which may not prove to be accurate. These statements are not guarantees and are subject to risks, uncertainties and changes in circumstances that are difficult to predict. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Among these factors are (1) our ability to identify and respond to new and changing fashion trends, customer preferences and other related factors; (2) our ability to execute successfully our growth strategy; (3) changes in consumer spending and general economic conditions; (4) changes in the competitive environment in our industry and the markets we serve, including increased competition from other retailers; (5) our new stores or existing stores achieving sales and operating levels consistent with our expectations; (6) the success of the malls and shopping centers in which our stores are located; (7) our dependence on a strong brand image; (8) our direct business growing consistently with our growth strategy; (9) our information technology systems supporting our current and growing business, before and after our planned upgrades; (10) disruptions to our information systems in the ordinary course or as a result of systems upgrades; (11) our dependence upon key executive management or our inability to hire or retain additional personnel; (12) disruptions in our supply chain and distribution facility; (13) our lease obligations; (14) our reliance upon independent third-party transportation providers for all of our product shipments; (15) hurricanes, natural disasters, unusually adverse weather conditions, boycotts and unanticipated events; (16) the seasonality of our business; (17) increases in costs of fuel, or other energy, transportation or utilities costs and in the costs of labor and employment; (18) the impact of governmental laws and regulations and the outcomes of legal proceedings; (19) our maintaining effective internal controls; and (20) our ability to protect our trademarks or other intellectual property rights.

 



 

BODY CENTRAL CORP.

 

(UNAUDITED)

 

NON-GAAP MEASURES

 

Net (Loss) Income

 

 

 

Thirteen Weeks Ended

 

Twenty-Six Weeks Ended

 

 

 

June 29,

 

June 30,

 

June 29,

 

June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

(in thousands, except share

 

 

 

and per share data)

 

 

 

 

 

Net (loss) income, as reported

 

$

(12,768

)

$

3,449

 

$

(10,071

)

$

9,388

 

Direct business impairment

 

10,358

 

 

10,358

 

 

Net (loss) income, as adjusted

 

$

(2,410

)

$

3,449

 

$

287

 

$

9,388

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share, as reported:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.78

)

$

0.21

 

$

(0.62

)

$

0.58

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

$

(0.78

)

$

0.21

 

$

(0.62

)

$

0.57

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share, as adjusted:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.15

)

$

0.21

 

$

0.02

 

$

0.58

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

$

(0.15

)

$

0.21

 

$

0.02

 

$

0.57

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

16,342,419

 

16,180,104

 

16,293,042

 

16,152,007

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

16,342,419

 

16,364,447

 

16,293,042

 

16,361,514

 

 



 

BODY CENTRAL CORP.

CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME (UNAUDITED)

 

 

 

Thirteen Weeks Ended

 

Twenty-Six Weeks Ended

 

 

 

June 29,

 

June 30,

 

June 29,

 

June 30,

 

 

 

2013

 

2012

 

2013

 

2012

 

 

 

(in thousands, except share

 

 

 

and per share data)

 

 

 

 

 

Net revenues

 

$

75,147

 

$

79,355

 

$

156,550

 

$

162,036

 

Cost of goods sold, including occupancy, buying, distribution center and catalog costs

 

54,525

 

54,622

 

108,285

 

108,041

 

Gross profit

 

20,622

 

24,733

 

48,265

 

53,995

 

Selling, general and administrative expenses

 

22,924

 

17,852

 

44,927

 

36,102

 

Depreciation

 

2,522

 

1,385

 

4,284

 

2,862

 

Impairment of long-lived assets

 

10,358

 

 

10,358

 

 

(Loss) income from operations

 

(15,182

)

5,496

 

(11,304

)

15,031

 

Interest income, net

 

8

 

 

9

 

7

 

Other income, net

 

979

 

15

 

1,008

 

58

 

(Loss) income before income taxes

 

(14,195

)

5,511

 

(10,287

)

15,096

 

(Benefit) provision for income taxes

 

(1,427

)

2,062

 

(216

)

5,708

 

Net (loss) income

 

$

(12,768

)

$

3,449

 

$

(10,071

)

$

9,388

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.78

)

$

0.21

 

$

(0.62

)

$

0.58

 

Diluted

 

$

(0.78

)

$

0.21

 

$

(0.62

)

$

0.57

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

16,342,419

 

16,180,104

 

16,293,042

 

16,152,007

 

Diluted

 

16,342,419

 

16,364,447

 

16,293,042

 

16,361,514

 

 



 

BODY CENTRAL CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

 

 

June 29.

 

June 30,

 

 

 

2013

 

2012

 

 

 

(In thousands, except share data)

 

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

 

$

31,543

 

$

26,447

 

Short-term investments

 

7,281

 

15,601

 

Accounts receivable

 

1,165

 

1,058

 

Inventories

 

25,208

 

18,103

 

Prepaid expenses and other current assets

 

10,061

 

6,518

 

Deferred tax asset

 

2,436

 

1,793

 

Total current assets

 

77,694

 

69,520

 

 

 

 

 

 

 

Property and equipment, net of accumulated depreciation

 

36,634

 

26,182

 

Goodwill

 

11,150

 

21,508

 

Intangible assets, net of accumulated amortization

 

16,574

 

16,395

 

Other assets

 

373

 

106

 

Total assets

 

$

142,425

 

$

133,711

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities

 

 

 

 

 

Merchandise accounts payable

 

$

13,518

 

$

10,054

 

Accrued expenses and other current liabilities

 

21,783

 

15,465

 

Total current liabilities

 

35,301

 

25,519

 

Other liabilities

 

9,989

 

7,392

 

Deferred tax liability

 

5,442

 

4,001

 

Total liabilities

 

50,732

 

36,912

 

Commitments and contingencies

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Total stockholders’ equity

 

91,693

 

96,799

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

142,425

 

$

133,711

 

 



 

BODY CENTRAL CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

 

Twenty-Six Weeks Ended

 

 

 

June 29,

 

June 30,

 

 

 

2013

 

2012

 

 

 

(in thousands)

 

Cash flows from operating activities

 

 

 

 

 

Net (loss) income

 

$

(10,071

)

$

9,388

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation

 

4,284

 

2,862

 

Deferred income taxes

 

(333

)

(64

)

Tax benefits from stock-based compensation

 

 

(709

)

Amortization of premium discounts on investments, net

 

93

 

152

 

Stock based compensation

 

1,098

 

1,288

 

Loss on disposal of property and equipment

 

47

 

58

 

Loss on impairment

 

10,358

 

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

3,545

 

1,549

 

Inventories

 

(2,237

)

3,038

 

Prepaid expenses and other current assets

 

(3,226

)

(2,225

)

Merchandise accounts payable

 

(197

)

(6,444

)

Accrued expenses and other current liabilities

 

1,496

 

(2,434

)

Other liabilities

 

(505

)

(492

)

Net cash provided by operating activities

 

4,352

 

5,967

 

Cash flows from investing activities

 

 

 

 

 

Purchases of property and equipment

 

(6,901

)

(6,812

)

Purchases of short-term investments

 

(9,384

)

(16,885

)

Proceeds from sales of short-term investments

 

290

 

100

 

Proceeds from maturities of short-term investments

 

1,723

 

1,025

 

Net cash used in investing activities

 

(14,272

)

(22,572

)

Cash flows from financing activities

 

 

 

 

 

Proceeds from exercise of stock options

 

327

 

350

 

Tax benefits from stock-based compensation

 

 

709

 

Net cash provided by financing activities

 

327

 

1,059

 

Net decrease in cash and cash equivalents

 

(9,593

)

(15,546

)

Cash and cash equivalents

 

 

 

 

 

Beginning of year

 

41,136

 

41,993

 

End of period

 

$

31,543

 

$

26,447